Omniome Completes $60 Million Series B Financing To Advance Novel Genomic Sequencing TechnologyProceeds to fund further development of breakthrough DNA sequencing platform SAN DIEGO, July 30, 2018-- Omniome, Inc., developer of an innovative new DNA sequencing platform, today announced it has raised an additional $60 million with the completion of its Series B financing. The funding round was led by Decheng Capital and Hillhouse Capital Group, joined by Lam Research Capital and Nan Fung Life Sciences as well as current investors ARCH Venture Partners, Domain Associates, Biomatics Capital Partners and Altitude Life Science Ventures.